Baseline characteristics |
No Nephropathy |
Nephropathy |
Undetermined |
ACEIs/ARBs
(n=1,070) |
No ACEIs/ARBs
(n=1,557) |
ACEIs/ARBs
(n=1,106) |
No ACEIs/ARBs
(n=740) |
ACEIs/ARBs
(n=1,365) |
No ACEIs/ARBs
(n=2,108) |
Male |
380 (35.5) |
464 (29.8) |
460 (41.6) |
244 (33.0) |
398 (29.2) |
601 (28.5) |
Age, (year) |
61.8±10.2 |
59.2±11.5 |
62.4±10.6 |
62.1±12.0 |
62.4±10.4 |
59.6±11.8 |
Duration of DM, (year) |
10.1±7.2 |
9.1±7.4 |
12.1±8.1 |
11.9±8.3 |
10.7±7.2 |
9.1±7.1 |
Onset of DM, (year) |
51.7±10.9 |
50.1±11.1 |
50.3±11.3 |
50.2±12.1 |
51.6±10.5 |
50.4±11.3 |
Body mass index, (kg/m2) |
26.0±3.9 |
25.2±4.1 |
26.0±4.4 |
25.8±4.7 |
26.1±4.5 |
25.4±4.3 |
Systolic blood pressure, (mmHg) |
145.1±21.3 |
137.0±19.9 |
150.3±24.7 |
147.1±24.8 |
146.9±21.6 |
138.1±19.9 |
Diastolic blood pressure, (mmHg) |
79.0±11.2 |
77.0±10.7 |
79.4±12.6 |
77.4±11.6 |
80.6±10.8 |
79.0±10.3 |
HbA1C, (%) |
7.9±1.7 |
7.9±1.7 |
8.5±2.1 |
8.4±2.0 |
8.2±1.8 |
8.2±1.9 |
Cholesterol, (mmol/L) |
4.9±0.9 |
5.0±1.0 |
5.1±1.2 |
5.3±1.4 |
5.2±1.1 |
5.2±1.1 |
Triglyceride, (mmol/L) |
1.6±0.9 |
1.5±0.9 |
1.9±1.6 |
2.0±1.6 |
1.8±1.0 |
1.8±1.3 |
High density lipoprotein, (mmol/L) |
1.4±0.4 |
1.3±0.4 |
1.3±0.4 |
1.3±0.3 |
1.4±0.4 |
1.3±0.4 |
Low density lipoprotein, (mmol/L) |
2.8±0.8 |
2.9±0.8 |
3.0±1.0 |
3.0±1.1 |
3.1±0.9 |
3.0±0.9 |
Creatinine, (mmol/L) |
89.5±44.7 |
86.9±100.5 |
121.2±68.2 |
152.8±121.9 |
103.1±44.8 |
96.4±41.0 |
Ischemic heart disease |
88 (8.3) |
89 (5.7) |
119 (10.8) |
80 (10.9) |
147 (10.9) |
148 (7.1) |
History of dyslipidemia |
874 (81.7) |
1,130 (72.6) |
876 (79.2) |
563 (76.1) |
1,023 (74.9) |
1,386 (65.8) |
History of hypertension |
991 (92.6) |
609 (39.1) |
984 (89.0) |
530 (71.6) |
1,275 (93.4) |
939 (44.5) |
Smoking |
200 (18.7) |
276 (17.7) |
303 (27.4) |
165 (22.3) |
234 (17.1) |
376 (17.8) |
Alcohol drinking |
195 (18.2) |
245 (15.7) |
260 (23.5) |
143 (19.3) |
242 (17.7) |
412 (19.5) |
Use of insulin |
221 (20.7) |
300 (19.3) |
393 (35.5) |
310 (41.9) |
325 (23.8) |
461 (21.9) |
Use of antihyperglycemic drugs |
999 (93.4) |
1,246 (91.4) |
941 (85.1) |
522 (70.5) |
1,246 (91.3) |
1,891 (89.7) |
Use of antihypertensive drugs |
573 (53.6) |
484 (31.1) |
656 (59.3) |
478 (64.6) |
818 (59.9) |
794 (37.7) |
Use of antidyslipidemic drugs |
712 (66.5) |
895 (57.5) |
708 (64.0) |
442 (59.7) |
746 (54.7) |
917 (43.5) |
Propensity score |
0.50±0.12 |
0.42±0.12 |
0.51±0.14 |
0.48±0.14 |
0.47±0.13 |
0.40±0.13 |
|
